Advanced Malignancies Except Leukemia
1 clinical trials · Condition
◉ Watch Advanced Malignancies Except Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer (NCT00585195) | Pfizer | 2006-04-19 |
Track Advanced Malignancies Except Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.